Sections
1. Investment Snapshot
2. Price Chart
3. Valuation & Price Target
4. Business & Product Moat
5. Market & Macro
Discussion
Investment Snapshot
Price Chart
Valuation & Price Target
Business & Product Moat
Market & Macro
Discussion
Kailera Therapeutics, Inc.
Investment Snapshot
Symbol
KLRA
IPO Date (Actual)
2026-04-17
Offer Range
$16.00
Shares Offered
39.1M
Total Shares Post-IPO
162.7M
Market Cap
—
Target Price
$00.00Implied Upside vs Midpoint
$00.00Use of Proceeds
—
Price Chart
Historic Price Chart - KLRA
Valuation & Price Target
████████████████████
Business & Product Moat
████████████████████
Competitor Set
████████████████████Market & Macro
Sector context: Pharmaceutical Preparations
Same-industry IPOs from the last 365 days (as of 2026-06-04). Returns from IPO open price.
Median IPO open → current
-19.8%
win 25% · n=4Median first month
-17.3%
win 25% · n=4| Company | IPO Date | Open → Current | First Month |
|---|---|---|---|
AVLN Avalyn Pharma Inc. | 2026-04-30 | +11.0% | +11.0% |
GENB Generate Biomedicines, Inc. | 2026-02-27 | -3.1% | -14.4% |
CURX Curanex Pharmaceuticals Inc | 2025-08-26 | -92.4% | -83.5% |
PPCB Propanc Biopharma, Inc. | 2025-08-15 | -36.4% | -20.1% |